Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Rui Zhang Jiechen Zhu Yanan Liu Yuanqin Li Wenjing Liu Maowei Zhang Bi Chen Shuyang Zhu

Published in: International journal of chronic obstructive pulmonary disease (2020)

Compared to the conventional dose (4 mg/day), a high dose (8 mg/day) of NB improved pulmonary function and symptoms more effectively in the early treatment of AECOPD, especially when given as 4 mg twice daily.

Keyphrases

high dose
physical activity
depressive symptoms
drug induced
stem cell transplantation
hepatitis b virus
aortic dissection